West Coast Clinical Trials

You may receive:
- Up to $2000 for time and travel
- Study-related examination at no cost
- Comfortable accommodations

Qualifications:
- Female
- 45 – 85 years old
- Generally healthy

Participation in a research study may contribute to medication development for the next generation.

Contact us NOW

West Coast Clinical Trials
1-877-777-9228
ptinfo@wcctrials.com
5630 Cerritos Ave., Cypress, CA 90630

Are you in or near the Boston area? This study is for women who are ages 21-60 who have had their uterus removed. This research studies how testosterone in combination with estrogen affects a woman's mind and body.

Who should not participate: women who have had breast, ovarian, uterine or cervical cancer; women who have had blood clots in their legs or lungs and women who have a BMI (Body Mass Index) of 40 or more.

Compensation of $1,000.00 will be paid to those women who complete the 14 month study.

Please see the invitation letter below.

Dear Hyster Sisters Member,

My name is Suzanne Roth and I am a Nurse Practitioner and a Clinical Research Coordinator at Boston Medical Center. The Endocrinology department studies hormones and how they work in the human body.

Currently we are working with the OB/GYN department at Boston Medical Center on a research study that looks at the hormones testosterone and estrogen.

This study is for women who are ages 21-60 who have had their uterus removed. This research studies how testosterone in combination with estrogen affects a woman's mind and body.

If this sounds interesting and you would like to learn more, please give me a call and I can answer any questions you may have. Please remember that you must live in or near Boston, Massachusetts.

Thank you for your time and I look forward to hearing from you.

Sincerely,
Suzanne Roth, NP

Clinical Research Coordinator
Boston Medical Center
Tel: 617-414-2938
Suzanne.roth@BMC.org

February 22, 2006

Hystersister website users who have recently had a hysterectomy and have had their ovaries removed(within 1 month post-op) are invited to participate in a survey study by University of Iowa researchers. This web-based survey inquires about the experiences you've had following your hysterectomy. The survey may take 20-30 minutes to complete. You will also be invited to complete a follow-up web-based survey in 12 weeks. The Hystersisters website has generously agreed to award each woman who participates a Hystersisters gift badge for the time and effort to complete the initial survey. In addition, women who complete both the initial survey and the follow-up survey will receive a certificate of participation and will be entered into a raffle for a chance to receive $50.00.

<Survey Closed>

July 1, 2005

If you have already had first line treatment for ovarian cancer, and your cancer has returned, you may be eligible to participate in a clinical research study investigating the safety and effectiveness of an investigational drug, in combination with standard chemotherapy. [Click Here]

Please consider volunteering. Ovarian Cancer is diagnosed in more than 25,000 women in the United States and 2,500 women in Canada each year. Your involvement in clinical research may help other women with ovarian cancer, as well as women yet to be diagnosed.

May 11, 2005

Hystersister website users who have recently had a hysterectomy (within 1 month post-op) are invited to participate in a survey study by University of Iowa researchers. This web-based survey inquires about the experiences you've had following your hysterectomy. The survey may take 20-30 minutes to complete. You will also be invited to complete a follow-up web-based survey in 12 weeks. The Hystersisters website has generously agreed to award each woman who participates a Hystersisters gift badge for the time and effort to complete the initial survey. In addition, women who complete both the initial survey and the follow-up survey will receive a certificate of participation and will be entered into a raffle for a chance to receive $50.00.

[Survey Closed. Thank you for your participation]

January 20, 2005

This is a Phase III clinical trial (research study) of OvaRex® MAb (oregovomab) for women who have been diagnosed with Stage III/Stage IV ovarian cancer. OvaRex is a monoclonal antibody that targets CA125, a marker found in the blood associated with ovarian cancer. OvaRex is designed to help each patient’s immune system recognize ovarian cancer cells and fight their disease.

In this study, OvaRex is being used at a time shortly after successful front line therapy when there is no standard treatment. This period of time is called “watchful waiting”, and currently there are no approved products to treat ovarian cancer at this stage.

Click Here for More Info

December, 2004


Doctoral candidate is looking for any woman who has had a Hysterectomy under one year, or over more than a year ago for a Dissertation Study on Hysterectomy Outcomes.

Age is open, but all eligible participants must be involved in an intimate partner relationship and be willing to answer three Survey instruments about their sexual functioning, physical and emotional health, and partner relationship.

[Survey Closed. Thank you for your participation!]

November, 2004 - Ongoing


New clinical studies are being conducted throughout the U.S. to evaluate the safety and efficacy of Alista™, a topically applied product for the treatment of women with female sexual arousal disorder (FSAD) as a result of undergoing a hysterectomy. As there are no medications currently approved by the FDA for the treatment of diminished sexual arousal, these clinical studies are an important step in the development of new therapeutic options to provide women with useful treatments for decreased sexual arousal.

Click for more information

November, 2004

Hyster Sisters.com has created a Women's Health Survey to measure the needs and experiences of women both pre and post menopause. By participating in this online survey, you will be helping us to improve education among women and the broader medical community about issues that concern them.

November 2004 (Survey Closed)
To view results [Click Here]